-
Forward Look
FDA Proposes Action on E-CigarettesResearch into the safety of the new device continues.
by Sue Rochman
-
Survivor Profile
Knowing Her OptionsWhen Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors.
by Melissa Davlin
-
Get Involved
Taking the Chill Out of ChemoTeenager starts Get Cozy During Chemo to provide blankets for cancer patients in treatment.
by Leigh Zaleski
-
Editor's Letter
A Place in the ShadeMany people still consider a tan “healthy” and don't take measures to protect their skin from the sun.
by Kevin McLaughlin
-
Forward Look
A Global Perspective on CancerQ&A with Christopher P. Wild on World Cancer Report 2014.
by Sue Rochman
-
Forward Look
Efforts Underway to Raise the Legal Age to Buy TobaccoLocal laws strive to reduce the number of new smokers.
by Melissa Weber
-
Editor's Letter
The Promise of ImmunotherapyImmunotherapy is a breakthrough in cancer treatment, but more research is needed to broaden its impact.
by Kevin McLaughlin
-
Forward Look
Affordable Care Act to Cover Breast Cancer Risk Reduction DrugsMedications are an option for high-risk women, but few use them.
by Sue Rochman
-
Forward Look
Push Needed to Increase HPV Vaccination RatesPresident's Cancer Panel stresses reducing 'missed opportunities.'
by Sue Rochman
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore